Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain
Completed · Phase 1 · Has a placebo group
Conditions studied: Chronic Osteoarthritis Pain, Chronic Low Back Pain
In brief
The primary goal of this clinical trial is to learn if PIPE-791 is safe and well-tolerated in adults with chronic osteoarthritis pain (COAP) or chronic low back pain (CLBP). The study will also explore whether PIPE-791 lowers pain in people with COAP or CLBP. Subjects will: * Complete a washout period to stop their current pain medications. * Take a daily dose of PIPE-791 or placebo for 4 weeks, then reverse treatment assignment for another 4 weeks. * Record pain levels and track dosing in a daily e-diary. * Visit the clinic for checkups and lab tests throughout the study. * Complete phone assessments during the treatment periods.
Key facts
- Study ID
- NCT06810245
- Run by
- Contineum Therapeutics
- People needed
- 43
- Starts
- 2025-02-04
- Expected to finish
- 2026-01-20
- Last updated by the study team
- 2026-03-18
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Research Center — Phoenix, Arizona, United States
- Drug Studies America — Marietta, Georgia, United States
- Drug Trials America — Hartsdale, New York, United States
- Altoona Center of Clinical Research — Duncansville, Pennsylvania, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.